ALDH1L1 and lung cancer: In summary, targeting ALDH1L1 alone did not have an anti-cancer effect in the KrasLA2 lung cancer model, whereas simultaneous inhibition of ALDH1L1 and oxidative phosphorylation significantly decreased tumor formation.